Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CRBN Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119798218A details a high-yield synthesis for CRBN-based E3 ligase linkers, offering significant cost reduction and supply reliability for pharmaceutical intermediates.
Novel patent CN117924283A details high-yield spiro compound synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.